Graf Akcie ALBO (Albireo Pharma Inc). Diskuze k akciím ALBO. Aktuální informace ALBO.

Základní informace o společnosti Albireo Pharma Inc (Akcie ALBO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	596.38M
Hodnota podniku (EV)	431.86M
Tržby	9.241M
EBITDA	-131.69
Zisk	-135.70
Růst v tržbách Q/Q	26.99 %
Růst v tržbách Y/Y	-18.05 %
P/E (Cena vůči ziskům)	N/A
Forward P/E	1.08
EV/Sales	46.73
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	62.75
P/FCF	N/A
Price/Book	3.20
Účetní hodnota na akcii	9.71
Hotovost na akcii	13.46
FCF vůči ceně	-20.75 %
Počet zaměstnanců	90
Tržba na zaměstnance	102.678k
Profit margin	-1,295.53 %
Operating margin	-1,312.80 %
Gross margin	100.00 %
EBIT margin	-1,312.80 %
EBITDA margin	-1,425.06 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	37.68 %
EPS - Očekávaný růst příští rok	-45.92 %
Return on assets	-50.92 %
Return on equity	-82.94 %
ROIC	-42.72 %
ROCE	-63.02 %
Dluhy/Equity	0.58
Čistý dluh/EBITDA	6.79
Current ratio	7.23
Quick Ratio	7.23
Volatilita	3.56
Beta	1.13
RSI	54.28
Cílová cena analytiků	69
Známka akcie (dle analytiků)	1.13
Insider ownership	0.65 %
Institutional ownership	88.56 %
Počet akcií	19.256M
Procento shortovaných akcií	12.57 %
Short ratio	5.11 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2016
Země	United States

Finanční výsledky akcie ALBO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$9.636	$12.74	$0.001	$11.364	-	-
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	$9.636	$12.74	$0.001	$11.364	-	-
Research And Development Expenses	$45.575	$31.732	$12.991	$8.077	$3.682	$13.365
SG&A Expenses	$22.963	$18.061	$15.246	$15.786	$10.289	$6.402
Other Operating Income Or Expenses	$-2.21	$-0.837	$3.659	$0.205	-	-
Operating Expenses	$70.748	$50.63	$24.578	$23.658	$13.971	$19.767
Operating Income	$-61.112	$-37.89	$-24.577	$-12.294	$-13.971	$-19.767
Total Non-Operating Income/Expense	$-1.605	$-8.201	$0.375	$-3.994	$0.268	$1.059
Pre-Tax Income	$-62.717	$-46.091	$-24.202	$-16.288	$-13.703	$-18.708
Income Taxes	-	$0.02	$0.212	$0.062	$0.052	$0.029
Income After Taxes	$-62.717	$-46.111	$-24.414	$-16.35	$-13.755	$-18.737
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-62.717	$-46.111	$-24.414	$-16.35	$-13.755	$-18.737
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-62.717	$-46.111	$-24.414	$-16.35	$-13.755	$-18.737
EBITDA	$-60.985	$-37.845	$-24.379	$-11.215	$-13.89	$-19.57
EBIT	$-61.112	$-37.89	$-24.577	$-12.294	$-13.971	$-19.767
Basic Shares Outstanding	12	12	8	1	2	1
Shares Outstanding	12	12	8	1	2	1
Basic EPS	$-5.04	$-3.94	$-3.12	$-13.19	$-6.45	$-13.70
EPS - Earnings Per Share	$-5.04	$-3.94	$-3.12	$-13.19	$-6.45	$-13.70

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$131.843	$163.885	$53.231	$29.931	$28.705	$40.845
Receivables	-	-	$0.726	$0.37	-	-
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$9.956	$3.765	$1.054	$0.56	$0.13	$0.262
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$141.799	$167.65	$55.011	$30.861	$28.835	$41.107
Property, Plant, And Equipment	$0.597	$0.187	$0.178	$0.021	-	$0.28
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	$17.26	$17.26	$17.26	$18.26	$0.034	$0.037
Other Long-Term Assets	$5.413	$0.369	$0.775	$0.518	-	-
Total Long-Term Assets	$23.27	$17.816	$18.213	$18.799	$0.034	$0.317
Total Assets	$165.069	$185.466	$73.224	$49.66	$28.869	$41.424
Total Current Liabilities	$18.924	$12.825	$7.929	$12.708	$2.071	$1.808
Long Term Debt	-	-	$0.042	-	-	-
Other Non-Current Liabilities	$52.984	$50.004	-	-	$0.359	$0.059
Total Long Term Liabilities	$52.984	$50.004	$0.042	-	$0.359	$0.059
Total Liabilities	$71.908	$62.829	$7.971	$12.708	$2.43	$1.867
Common Stock Net	$0.127	$0.12	$0.089	$0.063	$0.021	$0.021
Retained Earnings (Accumulated Deficit)	$-159.187	$-96.47	$-50.359	$-25.945	$-262.051	$-248.296
Comprehensive Income	$6.452	$4.293	$1.001	$1.496	-	-
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$93.161	$122.637	$65.253	$36.952	$26.439	$39.557
Total Liabilities And Share Holders Equity	$165.069	$185.466	$73.224	$49.66	$28.869	$41.424

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-62.717	$-46.111	$-24.414	$-16.35	$-13.755	$-18.737
Total Depreciation And Amortization - Cash Flow	$0.127	$0.045	$0.198	$1.079	$0.081	$0.197
Other Non-Cash Items	$19.944	$17.138	$-1.158	$3.22	$0.435	$0.868
Total Non-Cash Items	$20.071	$17.183	$-0.96	$4.299	$0.516	$1.065
Change In Accounts Receivable	-	-	$-0.311	$1.104	-	-
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	$0.577	$3.171	$0.263	$-1.164	$-0.271	$0.249
Change In Assets/Liabilities	$-0.424	$0.205	$0.028	$0.327	-	-
Total Change In Assets/Liabilities	$-10.273	$2.126	$-2.192	$3.267	$0.699	$0.478
Cash Flow From Operating Activities	$-52.919	$-26.802	$-27.566	$-8.784	$-12.544	$-18.203
Net Change In Property, Plant, And Equipment	$-0.54	$-0.047	$4.31	$-0.003	$0.404	$0.007
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	$25.483	-	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	-	-	-	-	-	-
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$-0.54	$-0.047	$4.31	$25.48	$0.404	$0.007
Net Long-Term Debt	-	-	$-3.055	$-2.157	-	-
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	-	-	$-3.055	$-2.157	-	-
Net Common Equity Issued/Repurchased	$20.775	$94.15	$48.508	$0.079	-	$32.862
Net Total Equity Issued/Repurchased	$20.775	$94.15	$48.508	$9.769	-	$32.862
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$2.729	$45.032	$0.385	-	$-0.021	$1.591
Cash Flow From Financial Activities	$23.504	$139.182	$45.838	$7.612	$-0.021	$34.453
Net Cash Flow	$-32.042	$110.654	$23.3	$24.811	$-12.161	$16.257
Stock-Based Compensation	$7.578	$5.546	$3.7	$1.138	$0.637	$0.868
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	7.4931	13.0721	6.938	2.4285	13.9232	22.7362
Long-term Debt / Capital	-	-	0.0006	-	-	-
Debt/Equity Ratio	-	-	0.0006	0.0832	-	-
Gross Margin	100	100	-	100	-	-
Operating Margin	-634.2051	-297.4097	-	-108.1837	-	-
EBIT Margin	-634.2051	-297.4097	-	-108.1837	-	-
EBITDA Margin	-632.8871	-297.0565	-	-98.6888	-	-
Pre-Tax Profit Margin	-650.8613	-361.7818	-	-143.3298	-	-
Net Profit Margin	-650.8613	-361.9388	-	-143.8754	-	-
Asset Turnover	0.0584	0.0687	-	0.2288	-	-
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	-	-	0.0014	30.7135	-	-
Days Sales In Receivables	-	-	-	11.884	-	-
ROE - Return On Equity	-67.3211	-37.5996	-37.4144	-44.2466	-52.0254	-47.3899
Return On Tangible Equity	-82.63	-43.7581	-50.8699	-87.4706	-52.0924	-47.4114
ROA - Return On Assets	-37.9944	-24.8622	-33.3415	-32.9239	-47.6463	-45.2322
ROI - Return On Investment	-67.3211	-37.5996	-37.3903	-44.2466	-52.0254	-47.3671
Book Value Per Share	7.3073	10.2454	7.3293	5.8719	12.3662	19.0912
Operating Cash Flow Per Share	-1.9644	1.2353	3.5584	-1.2057	7.4378	12.9526
Free Cash Flow Per Share	-2.0038	0.6801	4.112	-1.3975	7.6221	13.0264

Premium

Tento článek patří k prémiovému obsahu našeho webu.

Již mám předplatné

Roční předplatné

Ušetříte 589 Kč oproti měsíčnímu předplatnému

2 999Kč

Objednat

Čtvrtletní předplatné

Ušetříte 98 Kč oproti měsíčnímu předplatnému

799Kč

Objednat

Měsíční předplatné

Předplatné našich prémiových služeb na měsíc.

299Kč

Objednat

Porovnání s konkurencí: Akcie ALBO

Společnost	P/E	PEG	Růst v tržbách (roční)	Růst v EPS	Return on equity	P/B	Profit margin
ALBO	N/A	N/A	-18.05 %	-45.92 %	-82.94 %	3.20	-1,295.53 %
Akcie OCUL	0.00	N/A	344.51 %	19.05 %	-174.71 %	11.57	-894.31 %
Akcie OCUL	0.00	N/A	344.51 %	19.05 %	-174.71 %	11.57	-894.31 %
Akcie OCUL	0.00	N/A	344.51 %	19.05 %	-174.71 %	11.57	-894.31 %

Nedávné obchody insiderů: Akcie ALBO

Jméno	Obchod	Cena	Objem
Jan Mattsson Chief Scientific Officer	Option 1 Mar 2021	$1.00	$39,330
Martha J. Carter Chief Regulatory Officer	Option 8 Sep 2020	$21.22	$636,600
Martha J. Carter Chief Regulatory Officer	Option 11 Sep 2020	$24.98	$249,800
Advisors Llcperceptive Life...	Nákup 14 Sep 2020	$40.00	$16,000,000
Pamela Stephenson Chief Commercial Officer	Prodej 25 Sep 2020	$33.20	$14,973
Simon N.R. Harford CFO and Treasurer	Prodej 12 Oct 2020	$37.30	$3,357
Jason Duncan Chief Legal Officer and GC	Prodej 22 Oct 2020	$34.71	$3,089
Patrick Taylor Horn Chief Medical Officer	Prodej 22 Oct 2020	$34.55	$3,075
Pamela Stephenson Chief Commercial Officer	Prodej 28 Dec 2020	$39.07	$17,972
Simon N.R. Harford CFO and Treasurer	Prodej 11 Jan 2021	$37.33	$4,106
Patrick Taylor Horn Chief Medical Officer	Prodej 21 Jan 2021	$34.62	$3,808
Jason Duncan Chief Legal Officer and GC	Prodej 21 Jan 2021	$34.62	$3,808
Martha J. Carter Chief Regulatory Officer	Option 8 Sep 2020	$21.22	$636,600
Martha J. Carter Chief Regulatory Officer	Option 11 Sep 2020	$24.98	$249,800
Advisors Llcperceptive Life...	Nákup 14 Sep 2020	$40.00	$16,000,000
Pamela Stephenson Chief Commercial Officer	Prodej 25 Sep 2020	$33.20	$14,973
Simon N.R. Harford CFO and Treasurer	Prodej 12 Oct 2020	$37.30	$3,357
Jason Duncan Chief Legal Officer and GC	Prodej 22 Oct 2020	$34.71	$3,089
Patrick Taylor Horn Chief Medical Officer	Prodej 22 Oct 2020	$34.55	$3,075
Pamela Stephenson Chief Commercial Officer	Prodej 28 Dec 2020	$39.07	$17,972
Simon N.R. Harford CFO and Treasurer	Prodej 11 Jan 2021	$37.33	$4,106
Patrick Taylor Horn Chief Medical Officer	Prodej 21 Jan 2021	$34.62	$3,808
Jason Duncan Chief Legal Officer and GC	Prodej 21 Jan 2021	$34.62	$3,808

JenAkcie

Graf Akcie ALBO (Albireo Pharma Inc). Diskuze k akciím ALBO. Aktuální informace ALBO.

Základní informace o společnosti Albireo Pharma Inc (Akcie ALBO)

Finanční výsledky akcie ALBO

Tento článek patří k prémiovému obsahu našeho webu.

Roční předplatné

Čtvrtletní předplatné

Měsíční předplatné

Porovnání s konkurencí: Akcie ALBO

Nedávné obchody insiderů: Akcie ALBO

Diskuze k akciím ALBO